Lv1
42 积分 2025-06-30 加入
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders
9天前
已完结
Receptor-Guided AAV Tropism Engineering via MATCH
9天前
已完结
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells
17天前
已完结
Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice
17天前
已完结
Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
17天前
已完结
FAP-α-Responsive Size-Transformable Lipid Nanoparticles for Stromal Remodeling and Enhanced Drug Penetration in Fibrotic Hepatocellular Carcinoma
24天前
已完结
Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells
30天前
已完结
Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities
1个月前
已完结
Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy
1个月前
已完结
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis
1个月前
已完结
皖公网安备34019202002308
